FAS Wealth Partners’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-28,031	Closed	-$1.85M	–	437
2024 Q3	$1.85M	Buy	28,031 +1,368	+5%	+$99.4K	0.15%	119
2024 Q2	$2.46M	Buy	26,663 +1,613	+6%	+$143K	0.21%	98
2024 Q1	$2.39M	Buy	25,050 +806	+3%	+$67.7K	0.21%	101
2023 Q4	$1.85M	Buy	24,244 +2,993	+14%	+$208K	0.18%	113
2023 Q3	$1.47M	Buy	+21,251	New	+$1.71M	0.16%	116
2023 Q2	–	Sell	-18,174	Closed	-$1.5M	–	424
2023 Q1	$1.5M	Buy	18,174 +4,438	+32%	+$349K	0.16%	112
2022 Q4	$1.02M	Buy	13,736 +1,809	+15%	+$139K	0.12%	142
2022 Q3	$986K	Buy	11,927 +2,082	+21%	+$200K	0.11%	129
2022 Q2	$936K	Buy	9,845 +2,369	+32%	+$245K	0.1%	132
2022 Q1	$880K	Buy	7,476 +2,139	+40%	+$240K	0.08%	147
2021 Q4	$691K	Buy	5,337 +2,391	+81%	+$279K	0.06%	161
2021 Q3	$334K	Buy	2,946 +871	+42%	+$99.4K	0.03%	224
2021 Q2	$215K	Buy	+2,075	New	+$196K	0.02%	268